Cipla share price

Cipla shares in focus after 100% acquisition of Inzpera Healthsciences; key details

Nov 04, 2025, 08:47 AM IST

Inzpera, incorporated in 2016, is engaged in the business of developing, manufacturing and marketing of differentiated paediatric pharmaceutical and wellness products.

Target prices for Sun Pharma, Lupin, Dr Reddy's, Zydus Life, Cipla: Q2 preview

Oct 08, 2025, 11:04 AM IST

The brokerage has maintained a ‘Positive’ sector view, forecasting EBITDA margins to remain “broadly stable” as companies focus on improving their product mix.

AB Capital, Cipla, APL Apollo Tubes: 3 stocks to buy for short-term gains

Aug 22, 2025, 07:23 AM IST

An analyst from Master Capital said that Cipla’s daily chart signals a bullish trend and the price has surged above both the 50-day EMA and the 200-day EMA , indicating strong upward momentum.

Paytm, Cipla, Wipro: How to trade these 3 buzzing largecap stocks

Apr 17, 2025, 07:29 AM IST

An analyst from YES Securities said that Despite recent weakness in the broader markets, Paytm has shown relative strength with its downside remaining limited.

Cipla shares: Nomura says 'Buy' pharma stock; target price set at Rs 1,780

Apr 14, 2025, 09:19 AM IST

Nomura India maintained its 'Buy' rating on Cipla Ltd, setting a target price of Rs 1,780 by March 2026. Cipla anticipates launching its gAbraxane product in 1HFY26 following USFDA approval.

Stock market today: Nifty levels to watch; trading views on Kotak Mahindra Bank, Cipla & Vedanta

Mar 19, 2025, 07:36 AM IST

An analyst from Master Capital said that Prices of Vedanta have exhibited strong bullish momentum, confirming a breakout above its trendline resistance.

Stock market today: Nifty levels to watch; trading views on Dr Reddys Labs, Cipla & Zydus Life

Mar 17, 2025, 07:34 AM IST

An analyst from Axis Securities said that Dr Reddy's Labs has shown signs of weakness following the formation of a double top around the Rs 1,400 level.

Tata Motors, Paytm, Cipla: How to trade these 3 buzzing stocks

Jan 09, 2025, 07:38 AM IST

An analyst from YES Securities said that Tata Motors has undergone a significant correction from its peak of Rs 1,179 over the past five months, reaching oversold territory.

Cipla, Glenmark Pharma, Lupin: How to trade these 3 buzzing pharma stocks

Nov 14, 2024, 07:23 AM IST

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, signaling a negative trend and sellers appear increasingly aggressive.

Bharat Electronics, Cipla, Titan: How to trade these 3 buzzing largecap stocks

Nov 05, 2024, 07:41 AM IST

An analyst at Anand Rathi said that BEL entered a corrective phase after reaching a high of Rs 340 in July 2024, characterized by a downtrend with consistently lower highs and lower lows.